
library_booksAll News
Page 1 of 6search
No articles match your search.


Tirzepatide and Ixekizumab Combo Shows 1-Year Trial Results

Study Links Medical Cannabis to Symptom Relief in Cancer Care

Statins May Cut Dementia Risk by Up to 15 Percent, Study Finds

Merck and Moderna say their custom-built mRNA vaccine, added to Keytruda, cut the chance of melanoma coming back in a 1,137-patient phase 3 trial, the first time an individualized cancer vaccine has won a trial this size, though the companies have not yet shown the actual numbers

A 4,429-patient international trial let a 50-gene tumour test decide who needed chemotherapy for hormone-driven early breast cancer, and 68% safely skipped it with almost identical survival five years on

A phase 3 trial gave 271 children and young adults intravenous arginine during a sickle cell pain crisis and found it did not shorten the crisis at all, while the hospital a child landed in mattered far more than whether they got the drug

A study of 28,720 UK adults tracked what happened after a type 2 diabetes diagnosis and found women slid toward mental health conditions while men hit heart and kidney disease earlier, yet both died sooner when diabetes and a mental health condition arrived together

An international trial of more than 500 early-stage rectal cancer patients found that a five-week course of chemoradiotherapy let four in five keep their rectum and avoid radical surgery at one year, sparing many a permanent stoma, though the long-term results are still to come

Tracking more than 376,000 people for up to 14 years, researchers at Karolinska Institutet found that people who actually did the free stool test had a 43% lower risk of dying from colorectal cancer, while simply being invited cut the risk 26%

Researchers in Spain and the Netherlands found older adults carrying Roseburia inulinivorans had markedly stronger grip, and mice given the microbe grew bigger, faster-twitch muscle, pointing to a real gut-muscle link that is still not proven in people

